Structural Evaluation of RYR2 -CPVT Missense Variants and Continuous Bayesian Estimates of Their Penetrance
Circulation: Genomic and Precision Medicine · 2026-04 · 19 (2)
DOI: 10.1161/circgen.125.005457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2026-04. Verfasst von Kundivy Dauda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Medicine and Clinical Pharmacology, Department of Medicine (K.D., M.K., D.W.M., A.S., L.V., B.C.K., B.M.K.). Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Mutation, Missense, Penetrance, Tachycardia, Ventricular. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is strongly associated with rare missense variants in RYR2 , the gene encoding the intracellular calcium release channel RyR2. METHODS: We curated 179 articles reviewed by 3 individuals to extrapolate RYR2 -CPVT missense variant genotype-phenotype relationships. Purportedly neutral control variants were ascertained from RYR2 missense variants observed in gnomAD and ClinVar. We performed an RYR2 -CPVT Bayesian penetrance analysis by conditioning a CPVT penetrance prior (hereafter called Bayesian CPVT-prior) on variant-specific features (in silico and structural) calibrated by heterozygote phenotypes. We evaluated various features, including the Bayesian CPVT-prior, ClinVar, REVEL, and AlphaMissense against our observed CPVT penetrance, using Spearman rank-order correlations and Brier Scores. Penetrance estimates were superimposed on a cryo-EM structure of RyR2 to investigate hot-spot heterogeneity. RESULTS: From the literature, we identified 1014 affected missense RYR2 heterozygotes (468 unique variants), and further supplemented by purpuroted unaffected heterozygotes in GnomAD to a total of 622 575 heterozygotes (5181 unique variants). Among the predictors, the Bayesian CPVT-prior score had the highest Spearman rank-order and lowest Brier scores, respectively (0.19; 0.0090), compared with ClinVar (0.083; 0.019), REVEL (0.16; 0.018), or AlphaMissense (0.18; 0.018). Penetrance estimates for all RYR2 missense variants are prospectively hosted at the Variant Browser website. CONCLUSIONS: Traditional categorical variant annotations limit accurate disease risk assessment, especially in populations unascertained for disease. A probabilistic, population-calibrated penetrance framework enables more meaningful prospective variant interpretation. Our Bayesian CPVT-prior outperforms current tools in evaluating RYR2 variant penetrance. We provide prospective Bayesian CPVT penetrance values for 29 242 RYR2 missense variants at our online variant browser.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genetic Medicine and Clinical Pharmacology, Department of Medicine (K.D., M.K., D.W.M., A.S., L.V., B.C.K., B.M.K.).
- Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan (K.Y.).
- Division of Cardiology, Department of Medicine (J.S.), Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN.
- Department of Pediatrics (P.J.K.), Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN.
- Department of Medicine, Brigham and Women's Hospital, Boston, MA (M.J.O.).
- Clinical Fellow, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.J.O.).
ORCID-Profile: Kundivy Dauda, Kohei Yamauchi, Devyn W Mitchell, Alex Shen, Loren Vanags, Jeffrey Schmeckpeper, Prince J Kannankeril, Bjorn C Knollmann, Brett M Kroncke
Förderung
- NHLBI NIH HHS
Zitieren
APA
Dauda, K., Yamauchi, K., Ku, M., Mitchell, D. W., Shen, A., Vanags, L., Schmeckpeper, J., Kannankeril, P. J., Knollmann, B. C., O'Neill, M. J., & Kroncke, B. M. (2026). Structural Evaluation of RYR2 -CPVT Missense Variants and Continuous Bayesian Estimates of Their Penetrance. Circulation: Genomic and Precision Medicine, 19(2). https://doi.org/10.1161/circgen.125.005457
Vancouver
Dauda K, Yamauchi K, Ku M, Mitchell DW, Shen A, Vanags L, et al. Structural Evaluation of RYR2 -CPVT Missense Variants and Continuous Bayesian Estimates of Their Penetrance. Circulation: Genomic and Precision Medicine. 2026;19(2). doi:10.1161/circgen.125.005457
BibTeX
@article{Dauda2026,
author = {Dauda, Kundivy and Yamauchi, Kohei and Ku, Matthew and Mitchell, Devyn W and Shen, Alex and Vanags, Loren and Schmeckpeper, Jeffrey and Kannankeril, Prince J and Knollmann, Bjorn C and O'Neill, Matthew J and Kroncke, Brett M},
title = {Structural Evaluation of RYR2 -CPVT Missense Variants and Continuous Bayesian Estimates of Their Penetrance},
journal = {Circulation: Genomic and Precision Medicine},
year = {2026},
volume = {19},
number = {2},
doi = {10.1161/circgen.125.005457}
}
EUVIMED